Based on the aggregated intelligence of 150,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, human tissue processing specialist CryoLife (NYSE: CRY) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at CryoLife's business and see what CAPS investors are saying about the stock right now.

CryoLife facts

Headquarters (Founded)

Kennesaw, Ga. (1984)

Market Cap

$212.3 million


Health-care equipment

Trailing-12-Month Revenue

$111.7 million


Founder/CEO Steven Anderson

CFO David Lee

Compound Annual Revenue and Net Income Growth (Over Past 3 Years)

11.2% and 187.6%

Cash / Debt

$30.1 million / $315,000


Baxter International (NYSE: BAX)

Edwards LifeSciences (NYSE: EW)

St. Jude Medical (NYSE: STJ)

Other Highly Rated Health-Care Equipment Stocks

Medtronic (NYSE: MDT)

Intuitive Surgical (Nasdaq: ISRG)

Zimmer Holdings (NYSE: ZMH)

Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.

On CAPS, 97% of the 311 members who have rated CryoLife believe the stock will outperform the S&P 500 going forward. These bulls include Ochlocracy and All-Star nibs61, who is ranked in the top 15% of our community.

Just last month, Ochlocracy helped Fools get to the heart of the matter:

Strengths: conservative management team and is a sole provider of pediatric heart valves. Company has growth potential with [BioGlue] and its derivatives, cryopatch and quick sealing surgical adhesive. Pipeline has a spinal disc.

Concerns: Merger complications with Medafor; Companies working on cardiac stem cells that may be able to repair heart tissue, however, I doubt this would apply to a malfunctioning or damaged pediatric heart valve.

In a pitch from two weeks earlier, nibs61 expands on CryoLife as a potent way to heal wounded portfolios:

[A] solid stock that is recession proof but what really made me look hard is their R&D projects. If they can get their BioGlue to work for herniated discs this could be off and running. Also they have government funding to research BioFoam to help … wounded soldiers in the field. Speculative on the upside and solid on the earnings side so as to not lose if the new projects don't come to fruition.

What do you think about CryoLife, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Intuitive Surgical is a Motley Fool Rule Breakers pick. The Fool owns shares of and has written puts on Medtronic. The Fool's disclosure policy always gets a perfect score.